LikeToWatchGirlsShit

What effect do the class action lawsuits pertaining to overprescribing antipsychotics like risperdal have on the future of the science of treatment?

They prevent them from wanting to develop more medications? Maybe they should just market them responsibly, thus avoiding needless legal exposure from selling themselves dishonestly. Effective medications with realistic outcome expectations will be profitable in the long term.

Some evidence of that would be welcome.